LAWRENCE, Mass., Nov. 4, 2011 /PRNewswire/ — NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, chief executive officer, will participate in the following schedule of investor conferences. Where possible, a webcast of the event will be made available at https://www.nxstage.com/ir.cfm at the time of each conference.
(Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO )
UBS Access Investor Day at The American Society of Nephrology Kidney Week
Friday, November 11, 2011 at 2:00 p.m. ET
Marriott Downtown Philadelphia
Philadelphia, PA.
Lazard Capital Markets 8th Annual Healthcare Conference
Tuesday, November 15, 2011 at 2:30 p.m. ET
The Pierre Hotel
New York, NY
23rd Annual Piper Jaffray Health Care Conference
Tuesday, November 29, 2011 at 11:30 p.m. ET
The New York Palace Hotel
New York, NY
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company’s website at https://www.nxstage.com.
Forward-Looking Statements
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words anticipate, believe, expect, estimate, plan, and similar expressions are generally intended to identify forward-looking statements. Examples of these forward-looking statements include statements as to Mr. Burbank‘s plans to present at these conferences. NxStage specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing NxStage’s expectations or beliefs as of any date subsequent to the date of this press release.
Contact:
Kristen K. Sheppard, Esq.
Investor Relations
ksheppard@nxstage.com
SOURCE NxStage Medical, Inc.
